Plasma proteins [27–29], lipids [30], Aβ42 and tau [31, 32] as well as proteins and microRNAs enclosed within exosomes and lysosomal derivatives have all been showing promise as biomarkers for early detection of AD pathology [33, 34]. Here, MAPT is linked to Alzheimer disease.